Lukas Hainz

A disease that steals movement while leaving thought intact demanded more than incremental symptom care, and that urgency set the stage for a candidate built to confront the fault line where motor neurons first begin to fail. AP-2, now entering first-in-human testing at La Princesa University

For adults carrying excess weight who are urged to “move more” yet face pain, low fitness, or limited mobility, the search for an exercise approach that is safe, approachable, and still effective can feel like an unsolved puzzle with too many missing pieces and too few realistic options. That

Decades of Alzheimer’s drug programs faltered because promising molecules either nudged the wrong levers of cell biology or stalled at the brain’s front door, and the result has been a cycle of costly starts and quiet sunsets that underscored how hard it is to increase autophagic clearance without

Ivan Kairatov brings a biopharma lens to clinician-AI collaboration, blending R&D rigor with practical know‑how from tech-enabled trials. In recent studies, chatbots not only matched but sometimes outperformed clinicians on management reasoning tasks, especially when teams used deliberate workflows

Hospitals needed faster answers while disease often hid in the subtle give, drag, and spring of living cells as they squeezed through microchannels and flowed past sensors that could now read mechanics at scale. That tension between urgency and nuance defined the promise of a new microfluidic

The strategic decision by Norfolk County councillors to authorize the sale of the Port Rowan Medical Centre represents a pivotal moment in the municipality's ongoing effort to divest itself from non-essential real estate holdings and focus on core service delivery. Located at 1035 Bay Street, this

The shift from merely documenting the slow decline of the human body to actively engineering its rejuvenation marks one of the most profound transitions in modern scientific history. Findings presented at the latest global summits indicate that the field of gerontology is no longer content with

Chronic kidney disease currently affects over one hundred million individuals across Europe, creating a public health crisis that demands sophisticated medical solutions beyond traditional therapy. While a kidney transplant remains the most effective intervention for patients facing end-stage renal

Achieving peak physical condition during the middle years of life acts as a powerful biological shield against the gradual onset of age-related health complications. While many individuals focus on the total number of years they might live, a shift in medical priorities toward the quality of those

Ivan Kairatov stands at the forefront of a biological revolution where ancient clinical practices meet the cutting-edge precision of biopharma and systems neuroscience. As an expert in neuroimmunology, he has spent years decoding how physical interventions can be translated into molecular signals